Pre‐existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma

Authors:

Abstract
Background Diabetes is a risk factor for various cancers, but its prognostic role in renal cell carcinoma (RCC) is controversial and understudied. The current study investigated the prognostic value of type 2 diabetes mellitus (T2DM) in RCC patients. Methods We reviewed the clinicopathological and follow‐up data of 451 RCC patients who received radical or partial nephrectomy at the First Hospital of Shanxi Medical University from 2013 to 2018. To evaluate the association of T2DM with RCC clinicopathological parameters, the Kaplan‐Meier method was used for survival estimates and Cox regression for univariate and multivariate analyses. A subgroup of T2DM patients was analyzed for the effect of laparoscopic versus open surgery on postoperative recurrence rates. Results Of the 451 patients, 74 (16.4%) had T2DM. These patients were older and had a higher body mass index, higher incidence rates of hypertension and cardiovascular morbidity, a higher rate of laparoscopic surgery, and smaller neoplasms (all P<0.05). T2DM patients exhibited shorter overall survival (OS), cancer‐specific survival (CSS) and recurrence‐free survival (RFS) (P=0.009, P=0.043, P=0.008, respectively) than patients without T2DM. T2DM (HR=3.391, 95% CI: 1.458‐7.886, P=0.005) and Fuhrman grade (HR=2.542, 95% CI: 1.115‐5.795, p=0.026) were independent predictors of OS, and T2DM was an independent predictor of CSS (HR=4.637, 95% CI: 1.420‐15.139, P=0.011) and RFS (HR=3.492, 95% CI: 1.516‐8.044, P=0.003). Among the 74 T2DM patients, different surgical approaches were irrelevant to RFS (P=0.728). Conclusions RCC patients with preexisting T2DM have a shorter OS and higher recurrence rate and mortality risk than those without T2DM.

This publication has 39 references indexed in Scilit: